WCG Clinical

MARCH 30, 2023

Uniform Live Action Training Using InvestigatorSpace Speeds Up Study Start Times In one case, a global pharmaceutical company used WCG’s training solutions to support two dermatology studies they were running. Study teams engaged with the training content throughout the trial and asked questions through the InvestigatorSpace platform.

Dermatology 52

Dermatology Clinical Trials Clinical Trials Trials 52

Pharmaceutical Technology

APRIL 13, 2023

Following the increased use of telemedicine during the Covid-19 pandemic, the potential of digital technologies in communication, data collection, and analysis has become increasingly realised by patients, healthcare systems, and clinical trial sponsors.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Dermatology 130

Drug Discovery World

MARCH 13, 2024

Johnson & Johnson has announced the first data from FRONTIER 2, the long-term extension of the Phase IIb FRONTIER 1 clinical trial evaluating JNJ-2113, the first and only investigational targeted oral peptide designed to block the IL-23 receptor. at 16 weeks and 76.2% at 52 weeks). .

Trials 52

Trials Dermatology Clinical Trials Clinical Trials 52

BioTech 365

JANUARY 15, 2022

Dermavant Presents New Patient Satisfaction Data from PSOARING 3 Long Term Extension Trial of Tapinarof in Adults with Plaque Psoriasis at the 2022 Winter Clinical Dermatology Conference Dermavant Presents New Patient Satisfaction Data from PSOARING 3 Long Term Extension Trial … Continue reading →

Dermatology 40

Dermatology Trials 40

Pharma Times

MARCH 10, 2023

Collaboration will concentrate on launching and running studies within medical dermatology

Clinical Trials 97

Clinical Trials Clinical Trials Dermatology Trials 97

pharmaphorum

JULY 5, 2022

Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies. With more than 500 dermatology clinical trials currently underway, it is often heard that there is a ‘’competition for participants’’. Patient recruitment for moderate or severe atopic dermatitis.

Trials 114

Trials Clinical Trials Clinical Trials Dermatology 114

Velocity Clinical Research

JULY 18, 2023

Born and trained in Egypt, he moved to the UK several years ago after working as a general practitioner there and deciding he loved the country and the clinical trial opportunities it offered. To join a clinical trial at Velocity, visit velocityclinicaltrials.com. By 2018, she was directing seven sites.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research 98

BioSpace

APRIL 21, 2021

On the back of the two positive Phase III trials, Ortho said it will submit a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2022.

Dermatology 98

Dermatology Trials Drugs 98

BioTech 365

SEPTEMBER 23, 2020

23, 2020 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that positive results from the two pivotal Phase III CAMP (Cantharidin … Continue reading →

Dermatology 40

Dermatology Trials Development 40

Pharmaceutical Technology

JANUARY 19, 2023

Concert’s patent portfolio includes oral Janus kinases JAK1/2 inhibitor, deuruxolitinib, to treat Alopecia Areata, an autoimmune dermatological disease. It is currently being evaluated in two open label, long-term extension trials in North America and Europe.

Dermatology 147

Dermatology Sales Drugs Production 147

Pharmaceutical Technology

JULY 12, 2022

A validated target in dermatology, PDE4 is an enzyme that induces overactive immune responses. The NDS submission by Arcutis is based on positive findings from the company’s pivotal Phase III programme and two long-term open-label clinical trials. Nearly one out of four subjects in these two trials were enrolled in sites in Canada.

Dermatology 162

Dermatology Immune Response Trials Clinical Trials 162

Pharmaceutical Technology

APRIL 19, 2023

“If approved, roflumilast foam would be the first topical drug with a new mechanism of action for this condition in over two decades, highlighting the unique formulation and deep dermatological expertise that Arcutis brings to immuno-dermatology.” The findings showed that the trial met its primary endpoint, with a 79.5%

Dermatology 130

Dermatology Trials Drugs Regulation 130

Fierce Pharma

MARCH 11, 2024

The disease setting currently has no approved treatment options.

Dermatology 102

Dermatology Sales Trials 102

XTalks

AUGUST 2, 2023

Eichenfield was also the principal investigator on clinical trials evaluating YCANTH. Verrica Pharmaceuticals is a dermatology therapeutics company developing medications for skin diseases that require medical interventions.

Life Science 52

Life Science FDA Approval Dermatology Pharmacy 52

XTalks

MAY 19, 2023

Clinical trials play a vital role in advancing patient treatment and medical care. This article delves into ten trends and statistics in the world of clinical trials for 2023. And don’t forget to explore the upcoming webinars about clinical trials on Xtalks to see what piques your curiosity about the latest clinical trial solutions.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

Fierce Pharma

OCTOBER 13, 2023

Now, the Danish dermatology specialist is peeling back the layers on those results.

Dermatology 110

Dermatology Trials 110

STAT News

DECEMBER 2, 2022

And a fragmented clinical trials industry has made it a prime target for private equity, which often consolidates markets by merging companies.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Dermatology 98

Drug Discovery World

MARCH 18, 2024

Targeted oral peptide JNJ-2113 maintained skin clearance in moderate-to-severe plaque psoriasis (PsO) through one year in the Phase 2b FRONTIER 2 clinical trial extension, Johnson & Johnson (J&J) has reported. JNJ-2113 is the first and only investigational targeted oral peptide designed to block the IL-23 receptor.

Dermatology 52

Dermatology Drugs Clinical Trials Clinical Trials 52

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. New sensor technology revolutionising data collection.

Clinical Trials 90

Clinical Trials Clinical Trials Trials Regulation 90

XTalks

APRIL 17, 2023

In clinical trials, patients experienced significantly clearer skin and less interference with sleep due to itch when taking lebrikizumab compared to placebo. The ADvocate1 and ADvocate2 Phase III studies were published in the New England Journal of Medicine and the British Journal of Dermatology , respectively.

Dermatology 97

Dermatology Antibody Clinical Trials Clinical Trials 97

Outsourcing Pharma

FEBRUARY 2, 2021

While the technology has been found mostly in dermatological applications, its use in studies is expanding, according to Illingworth Research Group.

Clinical Trials 64

Clinical Trials Clinical Trials Dermatology Trials 64

pharmaphorum

AUGUST 12, 2022

Patient recruitment specialist Clariness will deploy an app aimed at helping asthma patients monitor environment triggers and report symptoms in the clinical trials its support, thanks to a partnership with digital health firm DailyBreath. The post Clariness, DailyBreath partner to drive recruitment in asthma trials appeared first on.

Trials 52

Trials Clinical Trials Clinical Trials Dermatology 52

Pharmaceutical Technology

APRIL 17, 2023

The company will provide regulatory advice to Incannex, and manage clinical trials to develop CannQuit and ReneCann products to treat addiction and immune-disordered skin diseases. The company will help in managing the clinical trials of the products once the regulators provide approvals for the proposed research and development programmes.

Dermatology 130

Dermatology Clinical Trials Clinical Trials Production 130

Drug Discovery World

NOVEMBER 30, 2023

Biotechnology company Certa Therapeutics has revealed positive Phase II clinical trial data for FT011 in patients with scleroderma. The post Scleroderma drug trial shows up to 60% improvement appeared first on Drug Discovery World (DDW). I look forward to collaborating with the company in the FT011 development program ahead.”

Drug Trials 59

Drug Trials Trials Drugs Clinical Trials 59

Pharmaceutical Technology

MAY 19, 2023

The FDA nod means Rinvoq is now approved for seven indications in gastroenterology, rheumatology and dermatology. Based on the clinical trial results, treatment with Rinvoq shows both early and long-term symptom relief along with evidence of a visible reduction of damage to the intestinal lining caused by excess inflammation,” said Dr.

FDA Approval 264

FDA Approval Dermatology Sales Clinical Trials 264

Delveinsight

SEPTEMBER 28, 2021

Innovent, UNION Therapeutics Set to Advance Dermatology Market in China. Innovent Biologics and UNION therapeutics have announced a strategic and licensing collaboration to develop and commercialize Orismilast , a next-generation PDE4 inhibitor for inflammatory dermatology conditions in China.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Dermatology 80

The Pharma Data

OCTOBER 29, 2020

30, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today new data for baricitinib (marketed as OLUMIANT ® ) will be presented at the annual Fall Clinical Dermatology meeting taking place virtually October 29-November 1, 2020. INDIANAPOLIS , Oct.

Dermatology 52

Dermatology Development Medicine Clinical Trials 52

The Pharma Data

OCTOBER 1, 2021

Results from the Phase 3 POETYK PSO-1 and POETYK PSO-2 trials show that response rates for deucravacitinib continued to extend through Week 24 and were maintained through Week 52 in patients with moderate to severe plaque psoriasis. CESTidentified through 52 weeks of knowledge.

Dermatology 52

Dermatology Trials Clinical Development Research 52

Olympian Clinical Research

FEBRUARY 26, 2021

Clinical trials are research studies designed to evaluate or test a medical, surgical, or behavioral intervention. Most recently, clinical trials have gained recognition through the development and testing of Covid-19 vaccines. Today we’re taking some time to highlight a few of the biggest ones!

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

The Pharma Data

MAY 15, 2023

Positive data from two Phase 3 Dupixent ® (dupilumab) trials in prurigo nodularis published in Nature Medicine Positive results from two Phase 3 Dupixent ® (dupilumab) trials in adults with uncontrolled prurigo nodularis have been published in Nature Medicine. Results from the trials were the basis for the U.S.

Medicine 40

Medicine Trials Dermatology FDA Approval 40

Pharmaceutical Technology

FEBRUARY 28, 2023

Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data.

Generic Pharmaceutical 172

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 172

pharmaphorum

MAY 14, 2021

But Reuters reported that the doctor identified as its principal clinical trial investigator has said he is not in charge of the trial. Reuters quoted Kintor’s chief financial officer Lucy Lu, who said that Kayali was one of its trial investigators.

Drug Trials 52

Drug Trials Trials Drugs Dermatology 52

BioTech 365

OCTOBER 27, 2020

Safety and efficacy data from Phase II clinical trial of nomacopan in adults with mild to moderate BP The Phase II data was the basis for the agreement of the FDA and the EMA that Akari may proceed to a … Continue reading →

Dermatology 40

Dermatology Trials Clinical Trials Clinical Trials 40

Drug Discovery World

SEPTEMBER 13, 2022

In the Phase III POETYK PSO-1 and POETYK PSO-2 clinical trials, once-daily Sotyktu showed superior efficacy to placebo and twice-daily Otezla (apremilast) in 1,684 patients aged 18 years and older with moderate-to-severe plaque psoriasis. Psoriasis is a widely prevalent, immune-mediated disease that affects approximately 7.5

FDA Approval 52

FDA Approval Dermatology Clinical Trials Clinical Trials 52

pharmaphorum

MAY 18, 2021

Incyte has made further progress with its ruxolitinib cream, notching up a phase 3 trial showing it can re-pigment skin in vitiligo ahead of a key FDA decision in atopic dermatitis. The post Incyte preps second filing for ruxolitinib cream after vitiligo trial win appeared first on.

Trials 52

Trials Dermatology FDA Approval Medicine 52

XTalks

APRIL 26, 2023

Clinical Performance of Novel Elastic Scattering Spectroscopy (ESS) in Detection of Skin Cancer: A Blinded, Prospective, Multi-Center Clinical Trial [Initial Results]. Poster Presentation, Innovations in Dermatology Conference, Las Vegas, NV, November 3-5, 2022. Dermatology. Dermatology. 2004;208:27-31. 2000;200(1):11-16.

Life Science 52

Life Science Dermatology Clinical Trials Clinical Trials 52

pharmaphorum

SEPTEMBER 16, 2022

Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being. However, side effects do happen.

Dermatology 91

Dermatology Trials Drugs Development 91